The T/Bp values in HER2+ breast cancer showed a significant decrease in the LN metastases regarding PT (Figure 7), which may be due to crosstalking (cross-regulation), which occurs between integrins and EGFR receptors, such as HER2 [18,19]. Here, ERBB2 is linked to breast cancer.